CHICAGO--(BUSINESS WIRE)--Dr. George Gorodeski, Chief Scientist at CytoCore (OTCBB:CYCR), will present new aspects of his pioneering research that reveal the ability of the P2X7 receptor to screen uterine cancer and its implications for therapeutics and prevention at the Onco-Molecular Diagnostics Conference in San Francisco, June 7-8, 2007.
